Cargando…

Characteristics and background mucosa status of early gastric cancer after Helicobacter pylori eradication: A narrative review

Helicobacter pylori (H pylori) eradication treatment can reduce the risk of gastric cancer. However, early gastric cancer (EGC) can still be detected after eradication. Meanwhile, EGC after eradication is challenging to diagnose by an endoscopist in some cases due to the lack of apparent characteris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Yali, Jiang, Chen, Han, Yiping, Song, Wen, Li, Xiaoyu, Yin, Xiaoyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726367/ https://www.ncbi.nlm.nih.gov/pubmed/36482539 http://dx.doi.org/10.1097/MD.0000000000031968

Ejemplares similares

Endoscopic characteristics and high-risk background mucosa factors of early gastric cancer after helicobacter pylori eradication: a single-center retrospective study
por: Wei, Yali, et al.
Publicado: (2023)

Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: A retrospective study
por: Dore, Maria Pina, et al.
Publicado: (2018)

The influence of pretreatment with PPI on Helicobacter pylori eradication: A systematic review and meta-analysis
por: Kuang, Sheng, et al.
Publicado: (2021)

Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-Analysis
por: Chen, Han, et al.
Publicado: (2016)

Comparative study of magnifying narrow-band imaging and conventional white light endoscopy in the diagnosis of Helicobacter pylori status after eradication therapy
por: Tahara, Tomomitsu, et al.
Publicado: (2019)

Gastric microbiota in patients with Helicobacter pylori-negative gastric MALT lymphoma
por: Tanaka, Takahide, et al.
Publicado: (2021)

Probiotics for Standard Triple Helicobacter pylori Eradication: A Randomized, Double-blind, Placebo-controlled Trial
por: Hauser, Goran, et al.
Publicado: (2015)

Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial
por: Zhang, Di, et al.
Publicado: (2017)

A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication
por: Chuah, Seng-Kee, et al.
Publicado: (2016)

Efficacy of Helicobacter pylori eradication therapy for treatment of functional dyspepsia: A protocol for systematic review and meta-analysis
por: Wang, Jue, et al.
Publicado: (2021)

Helicobacter pylori eradication: Exploring its impacts on the gastric mucosa
por: Weng, Chun-Yan, et al.
Publicado: (2021)

Helicobacter pylori reinfection and its risk factors after initial eradication: A protocol for systematic review and meta-analysis
por: Li, Renliang, et al.
Publicado: (2021)

Association Between Early Helicobacter pylori Eradication and a Lower Risk of Recurrent Complicated Peptic Ulcers in End-Stage Renal Disease Patients
por: Chang, Shen-Shong, et al.
Publicado: (2015)

The efficacy and safety of Clostridium butyricum and Bacillus coagulans in Helicobacter pylori eradication treatment: An open-label, single-arm pilot study
por: Zhang, Jian, et al.
Publicado: (2020)

Seven-day triple therapy is sufficient to eradicate infection caused by Helicobacter pylori without 23S rRNA point mutation
por: Lee, Jung Wook, et al.
Publicado: (2021)

The efficacy and safety of different bismuth agents in Helicobacter pylori first-line eradication: A multicenter, randomized, controlled clinical trial
por: Cao, Yaping, et al.
Publicado: (2021)

A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience
por: Abd-Elsalam, Sherief, et al.
Publicado: (2016)

Multiple Genetic Analysis System-Based Antibiotic Susceptibility Testing in Helicobacter pylori and High Eradication Rate With Phenotypic Resistance-Guided Quadruple Therapy
por: Dong, Fangyuan, et al.
Publicado: (2015)

Halitosis and helicobacter pylori infection: A meta-analysis
por: Dou, Wenhuan, et al.
Publicado: (2016)

Long-term effects and benefits of Helicobacter pylori eradication on the gastric mucosa in older individuals
por: Chen, Jie, et al.
Publicado: (2022)

Local Immune Response in Helicobacter pylori Infection
por: Kivrak Salim, Derya, et al.
Publicado: (2016)

Eradication of Helicobacter pylori Increases Ghrelin mRNA Expression in the Gastric Mucosa
por: Lee, Eon Sook, et al.
Publicado: (2010)

Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial
por: Su, Jing, et al.
Publicado: (2017)

Association between Helicobacter pylori infection and colorectal polyps
por: Basmaci, Nergis, et al.
Publicado: (2023)

Morphologic characterization of residual DNA methylation in the gastric mucosa after Helicobacter pylori eradication
por: Tahara, Sayumi, et al.
Publicado: (2017)

Site-specific differences in T lymphocyte composition of the gastric mucosa after Helicobacter pylori eradication
por: Iwamuro, Masaya, et al.
Publicado: (2022)

The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori
por: Lee, Seung Woo, et al.
Publicado: (2020)

Helicobacter pylori prevalence in the Southwest of China: A protocol for systematic review
por: Wang, Rui, et al.
Publicado: (2020)

Characteristic analysis of early gastric cancer after Helicobacter pylori eradication: a multicenter retrospective propensity score-matched study
por: Liu, Xinyuan, et al.
Publicado: (2023)

Characteristics and predictors of gastric cancer after Helicobacter pylori eradication
por: Shichijo, Satoki, et al.
Publicado: (2018)

Atrophic gastritis and chronic diarrhea due to Helicobacter pylori infection in early infancy: A case report
por: Kakiuchi, Toshihiko, et al.
Publicado: (2019)

Helicobacter pylori infection in women with Hashimoto thyroiditis: A case-control study
por: Shmuely, Haim, et al.
Publicado: (2016)

Upregulation of Vanilloid Receptor-1 in Functional Dyspepsia With or Without Helicobacter pylori Infection
por: Choi, Yoon Jin, et al.
Publicado: (2016)

Biosynthesis, structure and biological function of cholesterol glucoside in Helicobacter pylori: A review
por: Zhang, Lanchi, et al.
Publicado: (2023)

A Rapid and Accurate Method to Evaluate Helicobacter pylori Infection, Clarithromycin Resistance, and CYP2C19 Genotypes Simultaneously From Gastric Juice
por: Kuo, Chao-Hung, et al.
Publicado: (2016)

Global knowledge mapping and emerging trends in Helicobacter pylori-related precancerous lesions of gastric cancer research: A bibliometric analysis from 2013 to 2023
por: Xiong, Meng, et al.
Publicado: (2023)

Characteristics and Early Diagnosis of Gastric Cancer Discovered after Helicobacter pylori Eradication
por: Ito, Masanori, et al.
Publicado: (2021)

Risk Factors for Gastric Cancer after the Eradication of Helicobacter pylori Evaluated Based on the Background Gastric Mucosa: A Propensity Score-matched Case-control Study
por: Obayashi, Yuka, et al.
Publicado: (2020)

Association between Helicobacter pylori infection and nonalcoholic fatty liver: A meta-analysis
por: Liu, Rongqiang, et al.
Publicado: (2019)

Impact of Helicobacter pylori eradication on the gastric microbiome
por: Mao, Li-Qi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ufe403crdaqhiv9i0sf6t3l5br